Drawing for GIINGER

USPTO serial 79381935

GIINGER

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
EISNACH, MICHAEL PATRICK
Law office
TMEG LAW OFFICE 104

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GIINGER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

THOMAS J. MANGO

THOMAS J. MANGO CANTOR COLBURN LLP20 CHURCH STREET22ND FLOORHARTFORD, CT 06103

Goods and services

ClassDescriptionStatusFirst use
009Equipment for data processing and computers; data banks being software, namely, recorded and downloadable software for medical and health research; software in the nature of recorded and downloadable software for database management and medical and health research; recorded and downloadable software for data analysis integrating automatic learning and artificial intelligence components; recorded and downloadable computer programs for data search, collection, management, storage and analysis; data processing apparatus; integrated circuits containing programs for audio, video or computer data processing; recorded or downloaded sounds, images or data, namely, downloadable and recorded audio files for medical, pharmaceutical, biopharmaceutical, and health research, downloadable and recorded image files for medical, pharmaceutical, biopharmaceutical, and health research, and downloadable and recorded data files for medical, pharmaceutical, biopharmaceutical, and health researchACTIVE—
042Project studies, technical research and appraisals, namely, medical, pharmaceutical, and biopharmaceutical project studies, medical, pharmaceutical, and biopharmaceutical technical research and medical and pharmaceutical and biopharmaceutical appraisals; writing, design, development and updating of software; technical support concerning the use of software, namely, troubleshooting of computer software problems and help desk services; hosting of online platforms for medical, pharmaceutical, and biopharmaceutical purposes; provision of non-downloadable software on line for medical and health research; providing temporary use of non-downloadable software on platforms, enabling users to access software, computer networks, computer servers and computer and electronic data storage systems; providing temporary use of non-downloadable software for importing, management and analysis of data, incorporating automatic learning and artificial intelligence components; providing software as a service (SAAS) featuring software for medical and health research; software as a service (SAAS) featuring software for automatic learning and artificial intelligence to be used for data analysis; providing scientific information in the field of medical and health research, and artificial intelligence via web- based platforms; electronic data storage and cloud computing services in the nature of providing, integration, hosting, and management of private and public cloud computing environments for bioinformatics analysis; bioinformatic analysis services, development of software and data pipeline architectures; providing methods and tools for calculations and bioinformatics for data analysis, namely, research and development services related to bioinformatics for data analysis; development and maintenance of data management software, database construction; development of genomic and bioinformatic applications; computerized electronic data storage; providing advice and information for the aforesaid servicesACTIVE—
044Medical services; health services, namely, healthcare research services; medical analysis services related to the treatment of individuals; medical diagnostic services, diagnostics in the field of medicine in the nature of medical diagnostic servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 22, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 20, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 14, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 12, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 25, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 25, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 13, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 12, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 12, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Jun 12, 2024CNSLSUSPENSION LETTER WRITTEN—
Jun 5, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 4, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 4, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 26, 2023RFNTREFUSAL PROCESSED BY IB—
Dec 5, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 5, 2023RFRRREFUSAL PROCESSED BY MPU—
Dec 5, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 4, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2023DOCKASSIGNED TO EXAMINER—
Nov 24, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 31, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 27, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 26, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance